Cagas, Eugenio B.
HRN: 11-61-62 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2026
CEFTRIAXONE 1G (VIAL)
06/06/2026
06/12/2026
IVTT
2g
OD
Cap-MR
Checking Initial Appropriateness
06/06/2026
AZITHROMYCIN 500MG TABLET (TAB)
06/06/2026
06/10/2026
ORAL
500 Mg/tab, 1 Tab
OD
Cap-MR
Checking Initial Appropriateness
06/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/11/2026
06/18/2026
IV
4.5g
Q6
Cap Hr
Checking Initial Appropriateness
06/14/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/14/2026
06/21/2026
IV
750mg
Q24
Cap Hr
Checking Initial Appropriateness
06/14/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/14/2026
06/21/2026
IV
400mg
Q24
Cap Hr; Ptb
Checking Initial Appropriateness
06/21/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/21/2026
06/28/2026
IV
900mg
Q8
Soft Tissue Infection
Checking Initial Appropriateness
06/21/2026
MUPIROCIN 2%, 15G (TUBE)
06/21/2026
06/28/2026
TOPICAL
2%
BID
Soft Tissue Infectiob
Checking Initial Appropriateness